Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2012
03/29/2012WO2012038454A1 Bvdv vaccine
03/29/2012WO2012038452A1 A method for keeping a foot-and-mouth disease vaccine available for emergency vaccination
03/29/2012WO2012038367A1 Therapeutic vaccination against active tuberculosis
03/29/2012WO2012038348A1 Recombinant mycobacterium as vaccine for use in humans
03/29/2012WO2012038055A1 Antigen-specific t cell receptors and t cell epitopes
03/29/2012WO2012037723A1 Attenuate live vaccine of vsocs gene-deleted megalocytivirus, method to prepare the same and use thereof
03/29/2012WO2012037612A1 Novel immunostimulatory method
03/29/2012WO2012016315A4 A recombinant strain of the bacterium brucella spp and live vaccine against brucellosis
03/29/2012WO2012015741A3 Combination therapy for treating cancer comprising an igf-1r inhibitor and an akt inhibitor
03/29/2012WO2012009640A3 B cell depletion for central nervous system injuries and methods and uses thereof
03/29/2012WO2011153485A3 Use of the sparc microenvironment signature in the treatment of cancer
03/29/2012WO2011150181A3 Compositions and methods for treating or inhibiting infection by francisella tularensis
03/29/2012WO2011142573A3 Vaccine composition containing a wta as an active ingredient
03/29/2012WO2011140267A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
03/29/2012WO2011140132A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
03/29/2012WO2011139974A3 Anti-pai-1 antibodies and methods of use thereof
03/29/2012WO2011139907A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
03/29/2012WO2011139801A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
03/29/2012WO2011138776A3 Biologic female contraceptives
03/29/2012WO2011133879A3 Combination therapies with mitochondrial-targeted anti-tumor agents
03/29/2012US20120079613 Homeobox Transcription Factor BSX and Uses Thereof for Treating Diseases, in Particular Obesity
03/29/2012US20120078028 Antibody drug conjugates (adc) that bind to 191p4d12 proteins
03/29/2012US20120076833 Surface-oriented antibody coating for the reduction of post-stent restenosis
03/29/2012US20120076831 Compositions and methods for induction of antigen-specific tolerance
03/29/2012US20120076828 Kanamycin antisense nucleic acid for the treatment of cancer
03/29/2012US20120076827 Compositions and methods for generating an immune response in a subject
03/29/2012US20120076826 Recombinantly Produced Allergens
03/29/2012US20120076825 Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
03/29/2012US20120076824 Novel edwardsiella ictaluri e-ict-vl33 strain, vaccines thereof, and a method for protecting fishes using said vaccines
03/29/2012US20120076823 Vector
03/29/2012US20120076822 Influenza vaccines with reduced amounts of squalene
03/29/2012US20120076821 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
03/29/2012US20120076820 Cd40l vaccines, compositions, and methods related thereto
03/29/2012US20120076818 Immunogenic composition and use thereof
03/29/2012US20120076817 Polysaccharide-protein conjugate vaccines
03/29/2012US20120076816 Novel malaria vaccine
03/29/2012US20120076815 Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/29/2012US20120076814 Combinations of pneumococcal rrgb clades
03/29/2012US20120076813 USES OF GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
03/29/2012US20120076812 Antiviral vaccines with improved cellular immunogenicity
03/29/2012US20120076811 Immunodominant compositions and methods of use therefor
03/29/2012US20120076810 Vaccinia virus polypeptides
03/29/2012US20120076808 Combined antigen and dna vaccine for preventing and treating autoimmune diseases
03/29/2012US20120076807 Plasmids with immunological action
03/29/2012US20120076806 Chloramphenicol Acetyl Transferase (CAT)-Defective Somatostatin Fusion Protein And Uses Thereof
03/29/2012US20120076804 Cancer targeted innate immunity
03/29/2012US20120076803 Antibodies to troponin i and methods of use thereof
03/29/2012US20120076802 Human cytomegalovirus neutralising antibodies and use thereof
03/29/2012US20120076801 Human cytomegalovirus neutralising antibodies and use thereof
03/29/2012US20120076800 Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations of Antibodies
03/29/2012US20120076799 Antagonists of pcsk9
03/29/2012US20120076798 Antagonistic Human LIGHT-Specific Human Monoclonal Antibodies
03/29/2012US20120076797 Modulation of kit signaling and hematopoietic cell development by IL-4 receptor modulation
03/29/2012US20120076796 Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
03/29/2012US20120076795 Anti-PECAM Therapy, Compositions, Methods, and Uses
03/29/2012US20120076794 Host cell specific binding molecules capable of neutralizing viruses and uses thereof
03/29/2012US20120076793 Agent for promoting hepatic cell replication and agent for improving insulin resistance
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/29/2012US20120076791 Methods Of Treating Chronic Prostatitis/Chronic Pelvic Pain Syndrome
03/29/2012US20120076790 Anti-cd48 antibodies and uses thereof
03/29/2012US20120076789 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
03/29/2012US20120076788 C-cbl and antagonists thereof for the treatment and diagnosis of cancer
03/29/2012US20120076787 Combination of a tnf-alpha antagonist and a vegf antagonist for use in the treatment or prevention of diseases of the eye
03/29/2012US20120076786 Bispecific antibodies
03/29/2012US20120076785 Method for inhibiting neurodegeneration
03/29/2012US20120076784 Highly concentrated, liquid formulations of anti-egfr antibodies
03/29/2012US20120076783 Reduced-viscosity concentrated protein formulations
03/29/2012US20120076782 Generation and profiling of fully human hucal gold®-derived therapeutic antibodies specific for human cd38
03/29/2012US20120076781 Methods of treating cancers with her3 antisense oligonucleotides
03/29/2012US20120076780 Recombinant fusion protein and polynucleotide construct for immunotoxin production
03/29/2012US20120076779 STABILIZATION OF IMMUNOGLOBULINS AND OTHER PROTEINS THROUGH AQUEOUS FORMULATIONS WITH SODIUM CHLORIDE AT WEAK ACIDIC TO NEUTRAL ph
03/29/2012US20120076778 Antibodies Against Insulin-Like Growth Factor I Receptor and Uses Thereof
03/29/2012US20120076777 Anti-fibroblastic fluorochemical emulsion therapies
03/29/2012US20120076776 Method for treating inflamation by lymphocyte depletion or sequestering
03/29/2012US20120076775 Combination of HGF Inhibitor and EGF Inhibitor to Treat Cancer
03/29/2012US20120076774 Detection and/or treatment of diseases associated with autoantibodies
03/29/2012US20120076773 Novel Drug Delivery Devices
03/29/2012US20120076772 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph
03/29/2012US20120076771 Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials
03/29/2012US20120076770 Modulation of autophagy and and serotonin for treatment of multiple myeloma related diseases
03/29/2012US20120076758 Antibodies against west nile virus and therapeutic and prophylactic uses thereof
03/29/2012US20120076756 Novel benzimidazole derivatives
03/29/2012US20120076755 Hepatitis C Virus Inhibitors
03/29/2012US20120076753 Use of nkp46 for preventing diabetes
03/29/2012US20120076752 Mesothelin Vaccines and Model Systems
03/29/2012US20120076735 Nanoparticles for Extravascular Administration
03/29/2012US20120076729 Methods of treating cancers
03/29/2012US20120076724 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
03/29/2012US20120076723 Devices and methods for the treatment of cancer
03/29/2012US20120076722 Methods for treating cancers and diseases associated with 4-1bb (cd137) expression
03/29/2012CA2814780A1 Carrier immunoglobulins and uses thereof
03/29/2012CA2813268A1 Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions
03/29/2012CA2812727A1 Anti-ephrin b2 antibody and its use
03/29/2012CA2812416A1 Human b1 cells and uses thereof
03/29/2012CA2812153A1 Antigen-specific t cell receptors and t cell epitopes
03/29/2012CA2811957A1 Novel immunostimulatory method
03/29/2012CA2811739A1 Recombinant viral vectors and methods for inducing an immune response to yellow fever virus
03/29/2012CA2811556A1 Breast cancer therapeutics
03/29/2012CA2811243A1 Bvdv vaccine
03/29/2012CA2811158A1 Recombinant mycobacterium as vaccine for use in humans
1 ... 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 ... 1823